Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.

O'Sullivan LA, Liongue C, Lewis RS, Stephenson SE, Ward AC.

Mol Immunol. 2007 Apr;44(10):2497-506. Epub 2007 Jan 17. Review.

PMID:
17208301
2.
4.

The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy.

Tao W, Wen F, Zhang H, Liu G.

Brain Dev. 2009 Mar;31(3):200-7. doi: 10.1016/j.braindev.2008.06.011. Epub 2008 Aug 19. Review.

PMID:
18715729
5.

Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis.

Ortiz-Muñoz G, Martin-Ventura JL, Hernandez-Vargas P, Mallavia B, Lopez-Parra V, Lopez-Franco O, Muñoz-Garcia B, Fernandez-Vizarra P, Ortega L, Egido J, Gomez-Guerrero C.

Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):525-31. doi: 10.1161/ATVBAHA.108.173781. Epub 2009 Jan 22.

6.

Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3.

Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A.

Arterioscler Thromb Vasc Biol. 2011 May;31(5):980-5. doi: 10.1161/ATVBAHA.110.207464. Review.

7.

Interleukins and STAT signaling.

Haque SJ, Sharma P.

Vitam Horm. 2006;74:165-206. Review.

PMID:
17027515
8.

Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies: implications for future therapeutic approaches.

Lai SY, Johnson FM.

Drug Resist Updat. 2010 Jun;13(3):67-78. doi: 10.1016/j.drup.2010.04.001. Epub 2010 May 14. Review.

PMID:
20471303
9.

Suppressors of cytokine signaling abrogate diabetic nephropathy.

Ortiz-Muñoz G, Lopez-Parra V, Lopez-Franco O, Fernandez-Vizarra P, Mallavia B, Flores C, Sanz A, Blanco J, Mezzano S, Ortiz A, Egido J, Gomez-Guerrero C.

J Am Soc Nephrol. 2010 May;21(5):763-72. doi: 10.1681/ASN.2009060625. Epub 2010 Feb 25.

10.

Expression of JAKs/STATs pathway molecules in rat model of rapid focal segmental glomerulosclerosis.

Liang Y, Jin Y, Li Y.

Pediatr Nephrol. 2009 Sep;24(9):1661-71. doi: 10.1007/s00467-009-1163-4. Epub 2009 Apr 7.

PMID:
19350281
11.

JAK/STAT signal transduction: regulators and implication in hematological malignancies.

Valentino L, Pierre J.

Biochem Pharmacol. 2006 Mar 14;71(6):713-21. Epub 2006 Jan 19. Review.

PMID:
16426581
12.

Jaks and cytokine receptors--an intimate relationship.

Haan C, Kreis S, Margue C, Behrmann I.

Biochem Pharmacol. 2006 Nov 30;72(11):1538-46. Epub 2006 Apr 27. Review.

PMID:
16750817
13.

[Negative regulation of the JAK/STAT: pathway implication in tumorigenesis].

Espert L, Dusanter-Fourt I, Chelbi-Alix MK.

Bull Cancer. 2005 Oct;92(10):845-57. French.

PMID:
16266868
14.

Suppressors of cytokine signaling as tumor repressors. Silencing of SOCS3 facilitates tumor formation and growth in lung and liver.

Baltayiannis G, Baltayiannis N, Tsianos EV.

J BUON. 2008 Apr-Jun;13(2):263-5. Review.

PMID:
18555475
15.

MsSOCS expression indicates a potential role for JAK/STAT signalling in the early stages of Manduca sexta spermatogenesis.

Elliott GC, Zeidler MP.

Insect Mol Biol. 2008 Sep;17(5):475-83. doi: 10.1111/j.1365-2583.2008.00804.x.

PMID:
18715265
16.

Dynamics and non-canonical aspects of JAK/STAT signalling.

Mohr A, Chatain N, Domoszlai T, Rinis N, Sommerauer M, Vogt M, Müller-Newen G.

Eur J Cell Biol. 2012 Jun-Jul;91(6-7):524-32. doi: 10.1016/j.ejcb.2011.09.005. Epub 2011 Oct 21. Review.

PMID:
22018664
17.

Jak/STAT/SOCS signaling circuits and associated cytokine-mediated inflammation and hypertrophy in the heart.

Terrell AM, Crisostomo PR, Wairiuko GM, Wang M, Morrell ED, Meldrum DR.

Shock. 2006 Sep;26(3):226-34. Review.

PMID:
16912647
18.

Evolution of JAK-STAT pathway components: mechanisms and role in immune system development.

Liongue C, O'Sullivan LA, Trengove MC, Ward AC.

PLoS One. 2012;7(3):e32777. doi: 10.1371/journal.pone.0032777. Epub 2012 Mar 7.

19.

Modeling regulatory mechanisms in IL-6 signal transduction in hepatocytes.

Singh A, Jayaraman A, Hahn J.

Biotechnol Bioeng. 2006 Dec 5;95(5):850-62.

PMID:
16752369
20.

A new pair of SOCS for diabetic nephropathy.

Brosius FC 3rd, Banes-Berceli A.

J Am Soc Nephrol. 2010 May;21(5):723-4. doi: 10.1681/ASN.2010030286. Epub 2010 Apr 22. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk